Agent Repurposing for the Treatment of Advanced Stage Diffuse Large B-Cell Lymphoma Based on Gene Expression and Network Perturbation Analysis

Over 50% of diffuse large B-cell lymphoma (DLBCL) patients are diagnosed at an advanced stage. Although there are a few therapeutic strategies for DLBCL, most of them are more effective in limited-stage cancer patients. The prognosis of patients with advanced-stage DLBCL is usually poor with frequen...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Chenxi, Ni, Huimin, Wang, Zhina, Ji, Binbin, Wang, Bo, Shi, Xiaoli, Wu, Wanna, Liu, Nian, Gu, Ying, Ma, Dongshen, Liu, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551569/
https://www.ncbi.nlm.nih.gov/pubmed/34721544
http://dx.doi.org/10.3389/fgene.2021.756784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551569/
https://www.ncbi.nlm.nih.gov/pubmed/34721544
http://dx.doi.org/10.3389/fgene.2021.756784

Ejemplares similares